Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation

• C Czoski-Murray,
• E Warren,
• J Chilcott,
• C Beverley,
• M Psyllaki,
• J Cowan

Affiliations

C Czoski-Murray

School of Health and Related Research (ScHARR), University of Sheffield, UK

E Warren

J Chilcott

C Beverley

M Psyllaki

J Cowan